norfloxacin has been researched along with amoxicillin in 57 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (12.28) | 18.7374 |
| 1990's | 10 (17.54) | 18.2507 |
| 2000's | 14 (24.56) | 29.6817 |
| 2010's | 19 (33.33) | 24.3611 |
| 2020's | 7 (12.28) | 2.80 |
| Authors | Studies |
|---|---|
| Apiwattanakul, N; Endou, H; Jariyawat, S; Kanai, Y; Sekine, T; Sophasan, S; Takeda, M | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
| Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P | 1 |
| Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
| Cattoir, V; Nordmann, P; Poirel, L | 1 |
| Baptista, BC; Correia, JD; da Fonseca, JD; Martínez-Martínez, L; Pomba, C | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Fàbrega, A; Martin, RG; Rosner, JL; Tavio, MM; Vila, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Avdeef, A; Tam, KY | 1 |
| Gozalbes, R; Pineda-Lucena, A | 1 |
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gao, F; Huang, G; Xiao, J | 1 |
| Beteck, RM; Jesumoroti, OJ; Legoabe, LJ; Patel, OPS | 1 |
| Bora, A; Deka, B; Devi, MV; Dihingia, A; Pahari, P; Sarma, S; Sen, T; Singh, AK; Suri, M | 1 |
| Desai, HG; Gill, HH; Kalro, RH; Mehta, PR; Murti, PK; Prabhu, SR; Ranganathan, S | 1 |
| Børsum, T; Dannevig, L; Melby, K; Størvold, G | 1 |
| Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Sato, K; Suzuki, Y; Tanaka, S; Yokota, N | 1 |
| Aragonés, E; Martí, R; Sarrà, N; Torres, M | 1 |
| Akita, H; Isohata, E; Iwata, S; Kawashima, C; Kin, Y; Kusumoto, Y; Oikawa, T; Sakamoto, H; Sato, Y; Yokota, T | 1 |
| DiPersio, JR; Ficorilli, SM; Kirk, M; Matsen, JM; Saxon, B; Spencer, HJ; Wright, DN | 1 |
| Claeys, G; Van den Abeele, AM; Verschraegen, G | 1 |
| Armynot du Chatelet, AM; Attisso, MA; Maillols, M; Simeon de Buochberg, M; Zuccarelli, M | 1 |
| Hill, S; Morgan, JR; Pathy, J; Yeates, M | 1 |
| Currie, WJ; Deaney, NB; Round, EM; VandenBurg, MJ; Vogel, R | 1 |
| Leigh, DA; Marriner, J; Smith, EC | 1 |
| Allocati, N; Catamo, G; Piccolomini, R | 1 |
| Andrews, JM; Brenwald, N; Wise, R | 1 |
| Gallés, C; Gasós, MA; Sauca, G | 1 |
| Attar, A; Bouhnik, Y; Flourié, B; Franchisseur, C; Rambaud, JC; Ruszniewski, P | 1 |
| Nakanishi, T; Nasu, T; Nishino, T; Okamoto, K | 1 |
| Kanayama, A; Kobayashi, I; Mochida, O; Naito, S; Saika, T; Tanaka, M; Tunoe, H | 1 |
| Katouno, Y; Kobayashi, Y; Sugita, K; Uchida, H | 1 |
| Babić-Erceg, A; Barisić, Z; Borzić, E; Carev, M; Kaliterna, V; Zoranić, V | 1 |
| De Neeling, AJ; Geerlings, SE; Hoepelman, AI; Meiland, R | 1 |
| Li, XD; Liu, YC; Xu, WH; Zhang, G; Zou, SC | 1 |
| Bedenic, B; Bubonja, M; Budimir, A; Topic, M | 1 |
| Alliot, F; Chevreuil, M; Dinh, QT; Eurin, J; Labadie, P; Moreau-Guigon, E | 1 |
| Antoniou, T; Garg, AX; Gomes, T; Hellings, C; Juurlink, DN; Mamdani, MM; Weir, MA; Yao, Z | 1 |
| Du, QP; Xu, JX; Xu, SH; Xu, YB; Zhang, XH; Zhou, Y | 1 |
| Chaminda, GT; Chiemchaisri, C; Chiemchaisri, W; Chulasak, R; Furumai, H; Honda, R; Masago, Y; Poonnotok, A; Sawaittayotin, V; Sienglum, C; Sunthonwatthanaphong, V; Tanong, K; Watanabe, T; Wongsila, K; Yamamoto, K | 1 |
| Abdenaceur, H; Beltifa, A; Ben Mansour, H; Ghorbel, A; Mehri, I; Reyns, T; Sire, O; Van Loco, J; Zouiten, A | 1 |
| Andrade, GI; Belo, NO; Carvalho, IA; Costa, EA; Costa, FN; Pereira, LS; Santos, RL | 1 |
| Chen, J; Du, Y; Guo, R; Mai, D; Wang, J; Xiang, Z; Zhu, F | 1 |
| Andrade, JC; Datiane de Morais Oliveira-Tintino, C; de Araújo Delmondes, G; de Oliveira Almeida, W; de Queiroz Dias, D; Ferreira, FS; Gadelha Rocha, MF; Martins da Costa, JG; Melo Coutinho, HD; Pereira da Silva, AR; Romeu da Nóbrega Alves, R; Sales, DL; Tintino, SR | 1 |
| De Oliveira, T; Guégan, R; Le Gleuher, J; Sugahara, Y | 1 |
| Asadi Karam, MR; Bouzari, S; Moazzezy, N; Oloomi, M; Rafati, S | 1 |
| Abebe, N; Ahmed, M; Awol, N; Bsrat, A; Gugsa, G; Hagos, Y; Tsegaye, Y | 1 |
| Guan, S; Huang, B; Li, P; Lin, G; Luan, T; Wang, Y; Yuan, K | 1 |
| Cui, X; Guo, Z; He, M; Li, T; Li, Y; Lin, C; Ouyang, W; Wang, J; Zhu, W | 1 |
3 review(s) available for norfloxacin and amoxicillin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Current scenario of tetrazole hybrids for antibacterial activity.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Tetrazoles | 2019 |
Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antiprotozoal Agents; Drug Development; Humans; Hypoglycemic Agents; Metronidazole | 2021 |
5 trial(s) available for norfloxacin and amoxicillin
| Article | Year |
|---|---|
Mono and dual therapy for Helicobacter pylori associated gastritis.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Norfloxacin; Organometallic Compounds; Tinidazole | 1991 |
A controlled trial of norfloxacin and amoxycillin in the treatment of uncomplicated urinary tract infection in the elderly.
Topics: Aged; Amoxicillin; Anti-Infective Agents, Urinary; Clinical Trials as Topic; Humans; Middle Aged; Nalidixic Acid; Norfloxacin; Urinary Tract Infections | 1985 |
Norfloxacin, amoxycillin, cotrimoxazole and nalidixic acid. A summary of 3-day and 7-day therapy studies in the treatment of urinary tract infections.
Topics: Amoxicillin; Anti-Infective Agents, Urinary; Bacteria; Drug Administration Schedule; Drug Combinations; Humans; Nalidixic Acid; Norfloxacin; Sulfamethoxazole; Time Factors; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1984 |
Comparative study using norfloxacin and amoxycillin in the treatment of complicated urinary tract infections in geriatric patients.
Topics: Aged; Amoxicillin; Anti-Infective Agents, Urinary; Cinoxacin; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Urinary Tract Infections | 1984 |
Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Breath Tests; Chronic Disease; Clavulanic Acid; Cross-Over Studies; Diarrhea; Double-Blind Method; Drug Combinations; Female; Humans; Hydrogen; Intestine, Small; Male; Middle Aged; Norfloxacin; Penicillins; Probiotics; Respiration; Saccharomyces | 1999 |
49 other study(ies) available for norfloxacin and amoxicillin
| Article | Year |
|---|---|
The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1.
Topics: Animals; Anion Transport Proteins; Anti-Bacterial Agents; Biological Transport; Carrier Proteins; Cell Survival; Cephaloridine; Cephalosporins; In Vitro Techniques; Kidney; Kinetics; Oocytes; p-Aminohippuric Acid; Penicillin G; Rats; Recombinant Proteins; Xenopus laevis | 1999 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship | 2007 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog.
Topics: Animals; Anti-Bacterial Agents; Dogs; Drug Resistance, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Plasmids; Virulence | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Constitutive SoxS expression in a fluoroquinolone-resistant strain with a truncated SoxR protein and identification of a new member of the marA-soxS-rob regulon, mdtG.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Regulon; Sequence Analysis, DNA; Trans-Activators; Transcription Factors | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cell Survival; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Multidrug Resistance-Associated Proteins; Quinazolines; Staphylococcus aureus; Structure-Activity Relationship; THP-1 Cells | 2022 |
Chlamydia trachomatis: in vitro susceptibility of genital and ocular isolates to some quinolones, amoxicillin and azithromycin.
Topics: Amoxicillin; Anti-Infective Agents; Azithromycin; Cervix Uteri; Chlamydia trachomatis; Ciprofloxacin; Conjunctiva; Drug Evaluation, Preclinical; Erythromycin; Female; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Urethra | 1990 |
[Antibacterial activity of ciprofloxacin against fresh clinical isolates from superficial suppurative foci].
Topics: Amoxicillin; Bacteria; Cefaclor; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Suppuration | 1991 |
[Single dose in therapeutic strategy in acute urinary tract infection].
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Female; Humans; Norfloxacin; Time Factors; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1990 |
[Antibacterial activity of norfloxacin on methicillin-resistant Staphylococcus aureus. Comparison with oral antibacterial agents].
Topics: Administration, Oral; Amoxicillin; Erythromycin; Methicillin; Minocycline; Norfloxacin; Penicillin Resistance; Staphylococcus aureus | 1990 |
Evaluation of four newer antimicrobial agents in the Avantage susceptibility test system.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria; Cefotetan; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Evaluation Studies as Topic; Microbial Sensitivity Tests; Norfloxacin | 1989 |
Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240).
Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefaclor; Ceftazidime; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Corynebacterium; Drug Combinations; Drug Resistance, Microbial; Fleroxacin; Norfloxacin; Pefloxacin; Piperacillin; Staphylococcus; Vancomycin | 1988 |
[Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus].
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Synergism; Enterococcus faecalis; Fosfomycin; Microbial Sensitivity Tests; Netilmicin; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Penicillin G; Vancomycin | 1988 |
Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
Topics: Amoxicillin; Anti-Infective Agents, Urinary; Bacteria; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Penicillin Resistance; Urinary Tract Infections | 1984 |
The in-vitro activity of OPC-17116, a new 5-methyl substituted quinolone.
Topics: Amoxicillin; Anti-Infective Agents; Bacteroides fragilis; Cefaclor; Chlamydia trachomatis; Chlamydophila pneumoniae; Ciprofloxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Norfloxacin; Piperazines; Protein Binding; Quinolones; Staphylococcus | 1993 |
[Changes in the sensitivity of Escherichia coli to 6 antimicrobial agents during the last 12 years. Group of Microbiologists of County Hospitals of Catalonia].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Escherichia coli; Gentamicins; Humans; Microbial Sensitivity Tests; Norfloxacin; Penicillins; Spain; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
[In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; beta-Lactams; Cefdinir; Cephalosporins; Clarithromycin; Escherichia coli O157; Fosfomycin; Kanamycin; Lactams; Microbial Sensitivity Tests; Minocycline; Norfloxacin; Shiga Toxin 1 | 1999 |
Antimicrobial activity of gemifloxacin (SB-265805), a newer fluoroquinolone, against clinical isolates of Neisseria gonorrhoeae, including fluoroquinolone-resistant isolates.
Topics: Amoxicillin; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Drug Resistance, Microbial; Fluoroquinolones; Gemifloxacin; Gonorrhea; Humans; Levofloxacin; Naphthyridines; Neisseria gonorrhoeae; Norfloxacin; Ofloxacin | 2000 |
[Comparative in vitro activities of several antimicrobial agents against Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Gastric Mucosa; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Penicillins; Stomach Ulcer | 2002 |
Urinary tract infections in South Croatia: aetiology and antimicrobial resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Ceftibuten; Cephalosporins; Clavulanic Acid; Croatia; Drug Resistance, Bacterial; Escherichia coli; Gram-Negative Bacteria; Humans; Nitrofurantoin; Norfloxacin; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections | 2003 |
Diabetes mellitus in itself is not a risk factor for antibiotic resistance in Escherichia coli isolated from patients with bacteriuria.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Bacteriuria; Ciprofloxacin; Diabetes Complications; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Middle Aged; Nitrofurantoin; Norfloxacin; Ofloxacin; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2004 |
Determination of selected antibiotics in the Victoria Harbour and the Pearl River, South China using high-performance liquid chromatography-electrospray ionization tandem mass spectrometry.
Topics: Amoxicillin; Anti-Bacterial Agents; China; Chloramphenicol; Chromatography, High Pressure Liquid; Climate; Erythromycin; Hong Kong; Macrolides; Norfloxacin; Ofloxacin; Quinolones; Rivers; Seasons; Seawater; Spectrometry, Mass, Electrospray Ionization; Sulfanilamides; Time Factors; Waste Management; Water Pollutants, Chemical | 2007 |
Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model.
Topics: Acetamides; Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactamases; Biomarkers; Cefadroxil; Ceftibuten; Cefuroxime; Cephalexin; Cephalosporins; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Middle Aged; Norfloxacin; Oxazolidinones; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2006 |
Measurement of trace levels of antibiotics in river water using on-line enrichment and triple-quadrupole LC-MS/MS.
Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, Liquid; Ciprofloxacin; Erythromycin; Fluoroquinolones; Hydrogen-Ion Concentration; Norfloxacin; Ofloxacin; Oxolinic Acid; Reproducibility of Results; Rivers; Solid Phase Extraction; Sulfamethoxazole; Tandem Mass Spectrometry; Tetracycline; Trimethoprim; Tylosin; Vancomycin; Water Pollutants, Chemical | 2011 |
Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study.
Topics: Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents, Urinary; Case-Control Studies; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hyperkalemia; Logistic Models; Male; Mineralocorticoid Receptor Antagonists; Nitrofurantoin; Norfloxacin; Odds Ratio; Ontario; Patient Admission; Risk; Spironolactone; Trimethoprim, Sulfamethoxazole Drug Combination | 2011 |
Combined toxic effects of heavy metals and antibiotics on a Pseudomonas fluorescens strain ZY2 isolated from swine wastewater.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Cephradine; Drug Resistance, Bacterial; Metals, Heavy; Microbial Sensitivity Tests; Norfloxacin; Pseudomonas fluorescens; Swine; Wastewater | 2015 |
Impacts of urbanization on the prevalence of antibiotic-resistant Escherichia coli in the Chaophraya River and its tributaries.
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Escherichia coli; Fluoroquinolones; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Rivers; Tetracycline; Thailand; Urbanization; Water Microbiology | 2016 |
Designation of pathogenic resistant bacteria in the Sparusaurata sea collected in Tunisia coastlines: Correlation with high performance liquid chromatography-tandem mass spectrometry analysis of antibiotics.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Aquaculture; Bacteria; Chloramphenicol; Chromatography, High Pressure Liquid; Colistin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Fish Diseases; Fisheries; Food Contamination; Fusidic Acid; Microbial Sensitivity Tests; Norfloxacin; Sea Bream; Seafood; Seawater; Tandem Mass Spectrometry; Tunisia; Vibrio alginolyticus; Vibrio Infections; Vibrio parahaemolyticus; Water Pollutants, Chemical | 2017 |
Frequency of enterotoxins, toxic shock syndrome toxin-1, and biofilm formation genes in Staphylococcus aureus isolates from cows with mastitis in the Northeast of Brazil.
Topics: Amoxicillin; Animals; Bacterial Toxins; Biofilms; Brazil; Cattle; Enterotoxins; Female; Gentamicins; Mastitis, Bovine; Norfloxacin; Staphylococcal Infections; Staphylococcus aureus; Superantigens; Virulence; Virulence Factors | 2018 |
Comprehensive assessment of three typical antibiotics on cyanobacteria (Microcystis aeruginosa): The impact and recovery capability.
Topics: Amoxicillin; Anti-Bacterial Agents; Cephradine; Glutathione; Malondialdehyde; Microcystis; Norfloxacin; Superoxide Dismutase | 2018 |
Body fat modulated activity of Gallus gallus domesticus Linnaeus (1758) and Meleagris gallopavo Linnaeus (1758) in association with antibiotics against bacteria of veterinary interest.
Topics: Adipose Tissue; Amikacin; Amoxicillin; Animals; Animals, Domestic; Anti-Bacterial Agents; Bacteria; Chickens; Fatty Acids; Microbial Sensitivity Tests; Norfloxacin; Poultry Diseases; Turkeys | 2018 |
Tuning down the environmental interests of organoclays for emerging pollutants: Pharmaceuticals in presence of electrolytes.
Topics: Adsorption; Amoxicillin; Carbamazepine; Cations; Electrolytes; Environmental Restoration and Remediation; Hydrophobic and Hydrophilic Interactions; Metoprolol; Norfloxacin; Pharmaceutical Preparations; Soil; Soil Pollutants; Sulfamethoxazole; Trimethoprim; Water; Water Pollutants, Chemical; X-Ray Diffraction | 2020 |
Inhibition and eradication activity of truncated α-defensin analogs against multidrug resistant uropathogenic Escherichia coli biofilm.
Topics: alpha-Defensins; Amoxicillin; Anti-Bacterial Agents; Biofilms; Cefixime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Norfloxacin; Uropathogenic Escherichia coli | 2020 |
Isolation, identification, and antimicrobial susceptibility pattern of Campylobacter jejuni and Campylobacter coli from cattle, goat, and chicken meats in Mekelle, Ethiopia.
Topics: Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Cattle; Chickens; Chloramphenicol; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Erythromycin; Ethiopia; Goats; Meat; Microbial Sensitivity Tests; Norfloxacin; Prevalence; Streptomycin; Sulfamethoxazole; Trimethoprim | 2021 |
Antibiotics in wastewater of Guangdong, China: distribution patterns, and their environmental risk due to incomplete removal.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; China; Ecosystem; Environmental Monitoring; Humans; Middle Aged; Norfloxacin; Ofloxacin; Sulfamethazine; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Young Adult | 2022 |
Occurrence, distribution, and potential ecological risks of antibiotics in a seasonal freeze-thaw basin.
Topics: Amoxicillin; Anti-Bacterial Agents; Environmental Pollutants; Humans; Norfloxacin; Rivers | 2023 |